WA1
CELG

Wimmer Associates 1’s Celgene Corp CELG Stock Holding History

Wimmer Associates 1’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,799
Closed -$250K – 109
2018
Q1 		$250K Buy
2,799
+30
+1% +$2.88K 0.22% 100
2017
Q4 		$289K Sell
2,769
-1,136
-29% -$128K 0.26% 96
2017
Q3 		$569K Sell
3,905
-375
-9% -$51.1K 0.52% 59
2017
Q2 		$556K Sell
4,280
-25
-0.6% -$3.06K 0.51% 60
2017
Q1 		$536K Buy
4,305
+1,620
+60% +$194K 0.5% 64
2016
Q4 		$311K Buy
2,685
+210
+8% +$23.4K 0.29% 90
2016
Q3 		$259K Buy
2,475
+205
+9% +$22.2K 0.23% 98
2016
Q2 		$224K Buy
+2,270
New +$235K 0.2% 105

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wimmer Associates 1's CELG Position: Q2 2018 in Review

Wimmer Associates 1 sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 2,799 shares — an estimated $250K sold.

Wimmer Associates 1 first reported a position in CELG in Q2 2016 and held it in 8 quarters. The position peaked at $569K in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Wimmer Associates 1 reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Wimmer Associates 1 sold 2,799 Celgene Corp shares in Q2 2018, an estimated $250K.
  • Wimmer Associates 1 first reported a position in Celgene Corp in Q2 2016 and held it in 8 quarters.
  • Wimmer Associates 1's Celgene Corp position peaked at $569K in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Wimmer Associates 1's 13F filing for Q2 2018, filed 14 Aug 2018.